| BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018 | ||||
| Theme: Rethinking the Next Big Things in Pharma Innovations | ||||
| Time: August 16-19, 2018 Place: Boston Marriott Cambridge, USA |
||||
| Scientific Program | ||||
| Stream 1 | Stream 2 | Stream 3 | Stream 4 | Stream 5 |
| Stream 3: Industrial Art Gallery -Arts in Billion Dollar Molecules and Next Generation Therapy |
Substream 3-1: Improved Linear Drug Discovery on Selected Current Drug Targets Substream 3-6: Clinical Trial Gateway and Translational Convergence |
| Substream 3-3: Follow-on Drugs and Repositioning Drug Discovery |
|||
|
Session 3301: Follow-on Drugs and Repositioning Drug Discovery Day 2: Morning, Friday, August 17, 2018 Place: Discovery Room, 3rd Floor 08:30-09:55 |
|||
| Chair: Dr. Raul Insa, CEO, SOM Biotech SL, Spain | |||
| Time | FaceOn | Speeches and Speakers | |
| 08:30-08:35 | Chair's Introduction | ||
| 08:35-08:55 |  |
Title: Lost Interest for Existing Compounds. Reviving Discontinued Molecules Dr. Lawrence Friedhoff, Chief, Research & Development, Roivant Sciences, Inc., USA |
|
| 08:55-09:15 |  |
Title: Drug Repositioning; A Systematic Approach in Rare Diseases Dr. Raul Insa, CEO, SOM Biotech SL, Spain |
|
| 09:15-09:35 |  |
Title: Exploiting Real World Evidence for Finding Opportunities for Drug Repurposing |
|
| 09:35-09:55 |  |
Title: Novel Strategies for the Development of Analgesics for Central Neuropathic Pain Dr. Christine N. Sang, Director, Translational Pain Research, Brigham and Women’s Hospital; Associate Professor, Harvard Medical School, USA |
|
| 09:55-10:05 | Coffee Break | ||
© 2003-2018 All rights reserved by BITeomics Inc. |